Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients
暂无分享,去创建一个
Anne Vincent-Salomon | Patricia de Cremoux | J. Thiery | A. Vincent-Salomon | J. Pierga | P. de Cremoux | H. Magdelenat | C. Nos | P. Pouillart | Jean-Yves Pierga | Pierre Pouillart | Jean-Paul Thiery | Claude Nos | Nathalie Blin | Charlyne Bonneton | Henri Magdelénat | C. Bonneton | N. Blin
[1] R C Coombes,et al. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Ghossein,et al. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. , 2000, European journal of cancer.
[3] H Sommer,et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] K. Pantel,et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] W. J. Decker,et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] I. Vlachonikolis,et al. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] James N Ingle,et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] J. Pierga,et al. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] M Baum,et al. Polychemotherapy for early breast cancer: An overview of the randomised trials , 1998 .
[10] R. Gelber,et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] A. van Dalen,et al. Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 Workshop , 1998, Tumor Biology.
[12] R. Coombes,et al. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. , 1997, European journal of cancer.
[13] R. Coombes,et al. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study , 1999, The Lancet.
[14] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[15] E. Hovig,et al. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells , 1999, International journal of cancer.
[16] B. Asselain,et al. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. , 1996, British Journal of Cancer.
[17] R. Bast,et al. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support , 1996, Breast Cancer Research and Treatment.
[18] T. Reimer,et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[20] J. Rosai,et al. Molecular detection of micrometastases and circulating tumor cells in solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] Robert J. Mayer,et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.
[22] T. Dimpfl,et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.
[23] R. Cote,et al. Detection and clinical importance of micrometastatic disease. , 1999, Journal of the National Cancer Institute.
[24] T. Fehm,et al. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. Rodenhuis,et al. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[27] I. Diel. Bone marrow staging for breast cancer: is it better than axillary node dissection? , 2001, Seminars in oncology.
[28] I. Funke,et al. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] R. Cote,et al. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. , 1991, Cancer research.
[30] I. Vlachonikolis,et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] S. Braun,et al. Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.
[32] O. Delattre,et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] G Kvalheim,et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. , 1999, Cytotherapy.
[34] R. Coombes,et al. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[36] H Stein,et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[37] R. Holle,et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.
[38] O. Delattre,et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] D. Weaver,et al. Breast Cancer Cells in the Blood: A Pilot Study , 1999, The breast journal.
[40] H. Vetter,et al. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.